Jump to content

chumma

Members
  • Posts

    23
  • Joined

  • Last visited

Everything posted by chumma

  1. http://medicineworld.org/cancer/lung/lu ... -blog.html An interesting lung cancer site with lung cancer blog
  2. I am glad you are getting the best treatment Carbo/Taxol/Avastin Betsy
  3. Sounds like enlarged lymph nodes Betsy
  4. Even though Avastin in combination with carboplatin and taxol has shown improved survival, this drug is still waiting for FDA approval. Why don't some blockheads in Washington make the approval process faster? Betsy
  5. I cannot agree more with the views expressed by Scott regarding urgent need for increased federal funding for lung cancer research. http://medicineworld.org/cancer/lung/lu ... al-funding Regards, Betsy
  6. Iressa failed to show survival advantage in a large clinical trial. You may read the FDA notification regarding this issue at http://medicineworld.org/news/lungNews.html Tarceva, taxotere and alimta are still options in this setting Regards Betsy
  7. Dear Kim Are you askin about clinical trials in general? If this is the case the following link will help you http://www.cancer.gov/clinicaltrials If you are asking about the durg L-BLP25, the company is only planning for a phase III trial. You may get more information on this by calling 1-877-234-0444, ext. 500. Press '4' and leave your name and telephone number with the area code. Regards, Betsy
  8. Vaccine increases survival in advanced non-small cell lung cancer http://medicineworld.org/news/lungNews.html Regards and good luck to all, Betsy
  9. FDA approves Tarceva for non-small cell lung cancer, that's very good news http://medicineworld.org/news/lungNews.html Best wishes Betsy
  10. Hope everyone take some red wine and enjoy Regards, Betsy
  11. Red Wine Slows Lung Cancer, White Raises Risk-Study Drink lot of redwine guys http://medicineworld.org/news/lungNews.html Regards, Betsy
  12. Genentec and OCI initiating a new Phase IIIB clinical trial for Tarceva in the treatment of non-small cell lung cancer. Anyone interested may visit this site. http://medicineworld.org/news/lungNews.html Genentech and OSI Pharmaceuticals Announced the Plan to Initiate Phase IIIB Clinical Study to Investigate the Efficiency of Tarceva Betsy
  13. Final survival data from more than 21,000 non-small cell lung cancer (NSCLC) patients http://medicineworld.org/news/lungNews.html Regards, Betsy
  14. FDA approves Alimta for the treatment of non-small cell lung cancer http://medicineworld.org/news/lungNews.html One more step forward in our fight with this disease Regards Betsy
  15. Machine helps lung cancer battle http://medicineworld.org/news/lungNews.html Regards, Betsy
  16. Minnie, Sorry to hear about your mother. Ask your doctor if gamma knife surgery is an option. Best wishes Betsy
  17. Blood Pressure Hormone May Inhibit Growth of Lung Cancer http://www.medicineworld.org/news/lungNews.html Regards, Betsy
  18. Twice daily radiotherapy without interruption gives better survival in small cell lung cancer than a once daily regime. http://medicineworld.org/news/lungNews.html Regards, Betsy
  19. A new study presente at ASCO (American Society of Medical Oncology) at New Orleans presented today shows a new drug Tarceva increases survival in lung cancer. Another study showed increased survival in patients treated with chemotherapy after surgery. http://www.medicineworld.org/news/lungNews.html Best wishes Betsy
  20. Rash is a very common side effect of Iressa. Some doctors say that the rash positively correlate with response. May be true. Regards, Betsy
  21. Pemetrexed is as good as docetaxel for treatment of lung cancer, but with less side effects http://medicineworld.org/cancer/page1.html Regards, Betsy
  22. New study shows mutations in genes predicts the response to tretment with Iressa for lung cancer. http://medicineworld.org/cancer/page1.html Regards, Betsy
  23. A japanese study shows this can add years to life, surprises U.S. Investigators. Good luck to all. http://medicineworld.org/cancer/page1.html Regards, Betsy
×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.